Abdelghani Omari
Direttore Finanziario/CFO presso PROTEOME SCIENCES PLC
Profilo
Abdelghani Omari is currently the Chief Financial Officer & Executive Director at Proteome Sciences Plc.
He is also a Director at TheraSci Ltd., a Co-Managing Director at Paion Deutschland GmbH, and a Managing Director & Director at Paion Holdings UK Ltd.
Mr. Omari previously served as a Non-Executive Director at PAION, Inc. and as the Chief Financial Officer at PAION AG from 2014 to 2022.
He obtained his undergraduate degree from RWTH Aachen University.
Posizioni attive di Abdelghani Omari
Società | Posizione | Inizio |
---|---|---|
PROTEOME SCIENCES PLC | Direttore Finanziario/CFO | 01/09/2022 |
Paion Holdings UK Ltd.
Paion Holdings UK Ltd. Financial ConglomeratesFinance Part of PAION AG, Paion Holdings UK Ltd. functions as an investment holding company. The company is based in Edinburgh, UK. The British company was founded in 1996. Abdelghani Omari has been the CEO of the company since 2012. | Amministratore Delegato | 07/02/2012 |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Amministratore Delegato | - |
Paion UK Ltd.
Paion UK Ltd. Pharmaceuticals: MajorHealth Technology Part of PAION AG, Paion UK Ltd. is a specialty pharmaceutical company that develops and commercializes innovative drugs for out-patient and hospital-based sedation and critical care services. Paion was founded in 1995 and is based in Cambridge, UK, with another site in Germany. Paion's vision is to become an acknowledged "PAIONeer" in sedation and critical care services. The British company's lead compound is remimazolam, an intravenous, ultra-short-acting and controllable benzodiazepine sedative/anesthetic drug candidate. The company is mainly focusing on completing the development program for procedural sedation and planning to continue the clinical development program for remimazolam in the indication general in the EU. | Direttore/Membro del Consiglio | 07/02/2012 |
TheraSci Ltd.
TheraSci Ltd. Pharmaceuticals: MajorHealth Technology TheraSci Ltd. provides health supplements for doctors, healthcare practitioners, and medical professionals. The private company is based in Cambridge, UK and was founded by Ann Gail Hayes. The British company's products include supplements for cardiometabolic, gastrointestinal, immune health, pain, hormone support, stress, sleep support, general wellness, and body composition. TheraSci aims to provide a high-quality nutraceutical sales and service platform that streamlines the product purchase and delivery process, while minimizing impact on physician workflow and optimizing patient health outcomes. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Abdelghani Omari
Società | Posizione | Fine |
---|---|---|
PAION AG | Direttore Finanziario/CFO | 01/06/2022 |
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The company is based in Mahwah, NJ. | Direttore/Membro del Consiglio | - |
Formazione di Abdelghani Omari
RWTH Aachen University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
PAION AG | Health Technology |
PROTEOME SCIENCES PLC | Health Technology |
Aziende private | 5 |
---|---|
TheraSci Ltd.
TheraSci Ltd. Pharmaceuticals: MajorHealth Technology TheraSci Ltd. provides health supplements for doctors, healthcare practitioners, and medical professionals. The private company is based in Cambridge, UK and was founded by Ann Gail Hayes. The British company's products include supplements for cardiometabolic, gastrointestinal, immune health, pain, hormone support, stress, sleep support, general wellness, and body composition. TheraSci aims to provide a high-quality nutraceutical sales and service platform that streamlines the product purchase and delivery process, while minimizing impact on physician workflow and optimizing patient health outcomes. | Health Technology |
Paion Deutschland GmbH
Paion Deutschland GmbH BiotechnologyHealth Technology Paion Deutschland GmbH engages in the development of pharmaceutical products. The company is headquartered in Aachen, Germany. | Health Technology |
PAION, Inc.
PAION, Inc. Pharmaceuticals: MajorHealth Technology Part of PAION AG, PAION, Inc. is a pharmaceutical manufacturing company. The company is based in Mahwah, NJ. | Health Technology |
Paion Holdings UK Ltd.
Paion Holdings UK Ltd. Financial ConglomeratesFinance Part of PAION AG, Paion Holdings UK Ltd. functions as an investment holding company. The company is based in Edinburgh, UK. The British company was founded in 1996. Abdelghani Omari has been the CEO of the company since 2012. | Finance |
Paion UK Ltd.
Paion UK Ltd. Pharmaceuticals: MajorHealth Technology Part of PAION AG, Paion UK Ltd. is a specialty pharmaceutical company that develops and commercializes innovative drugs for out-patient and hospital-based sedation and critical care services. Paion was founded in 1995 and is based in Cambridge, UK, with another site in Germany. Paion's vision is to become an acknowledged "PAIONeer" in sedation and critical care services. The British company's lead compound is remimazolam, an intravenous, ultra-short-acting and controllable benzodiazepine sedative/anesthetic drug candidate. The company is mainly focusing on completing the development program for procedural sedation and planning to continue the clinical development program for remimazolam in the indication general in the EU. | Health Technology |
- Borsa valori
- Insiders
- Abdelghani Omari